Athenahealth (ATHN) Misses Q1 EPS by 15c; Lowers Outlook
Athenahealth (NASDAQ: ATHN) reported Q1 EPS of $0.32, $0.15 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $285.4 million versus the consensus estimate of $297.56 million.
Based on the weaker than expected trends experienced in the first quarter of fiscal year 2017, we have revised our fiscal year 2017 guidance as of April 27, 2017. Our revised fiscal year 2017 financial guidance is summarized in the following table:
| For the Fiscal Year Ending December 31, 2017 | |||
| Financial Measures | |||
| GAAP Operating Income | $36 million - $46 million | ||
| Financial Metric | |||
| $350 million - $400 million |
For earnings history and earnings-related data on Athenahealth (ATHN) click here.